Zhen Dong Hu

Amphastar Nanjing Pharmaceuticals Co. Ltd. engages in the development and manufacture of injectable and inhalation products. The firm offers sodium, cosyntropin and hyaluronidase injections, anti-inflammatory drugs, local anesthesia, narcotic, and vitamin K1 injections. The company was founded on November 5, 2008 and is headquartered in Nanjing, China.

Amphastar Nanjing Pharmaceuticals Co. Ltd. engages in the development and manufacture of injectable and inhalation products. The firm offers sodium, cosyntropin and hyaluronidase injections, anti-inflammatory drugs, local anesthesia, narcotic, and vitamin K1 injections. The company was founded on November 5, 2008 and is headquartered in Nanjing, China.

Amphastar Nanjing Pharmaceuticals Co. Ltd. engages in the development and manufacture of injectable and inhalation products. The firm offers sodium, cosyntropin and hyaluronidase injections, anti-inflammatory drugs, local anesthesia, narcotic, and vitamin K1 injections. The company was founded on November 5, 2008 and is headquartered in Nanjing, China.

Amphastar Nanjing Pharmaceuticals Co. Ltd. engages in the development and manufacture of injectable and inhalation products. The firm offers sodium, cosyntropin and hyaluronidase injections, anti-inflammatory drugs, local anesthesia, narcotic, and vitamin K1 injections. The company was founded on November 5, 2008 and is headquartered in Nanjing, China.

Amphastar Nanjing Pharmaceuticals Co. Ltd. engages in the development and manufacture of injectable and inhalation products. The firm offers sodium, cosyntropin and hyaluronidase injections, anti-inflammatory drugs, local anesthesia, narcotic, and vitamin K1 injections. The company was founded on November 5, 2008 and is headquartered in Nanjing, China.